BillionToOne Inc/$BLLN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BillionToOne Inc
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Ticker
$BLLN
Sector
Primary listing
Employees
713
Headquarters
Website
BillionToOne Inc Metrics
BasicAdvanced
$3.2B
500.79
$0.14
-
-
Price and volume
Market cap
$3.2B
52-week high
$98.58
52-week low
$61.96
Average daily volume
325K
Financial strength
Current ratio
11.688
Quick ratio
11.209
Long term debt to equity
21.516
Total debt to equity
22.681
Interest coverage (TTM)
168.66%
Profitability
EBITDA (TTM)
22.933
Gross margin (TTM)
68.32%
Net profit margin (TTM)
0.96%
Operating margin (TTM)
5.25%
Effective tax rate (TTM)
3.93%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
2.14%
Return on equity (TTM)
2.30%
Valuation
Price to earnings (TTM)
500.789
Price to revenue (TTM)
3.648
Price to book
6.69
Price to tangible book (TTM)
6.69
Price to free cash flow (TTM)
71.014
Free cash flow yield (TTM)
1.41%
Free cash flow per share (TTM)
0.987
Growth
Revenue change (TTM)
99.97%
Earnings per share change (TTM)
-103.39%
What the Analysts think about BillionToOne Inc
Analyst ratings (Buy, Hold, Sell) for BillionToOne Inc stock.
BillionToOne Inc Financial Performance
Revenues and expenses
BillionToOne Inc Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BillionToOne Inc stock?
BillionToOne Inc (BLLN) has a market cap of $3.2B as of March 31, 2026.
What is the P/E ratio for BillionToOne Inc stock?
The price to earnings (P/E) ratio for BillionToOne Inc (BLLN) stock is 500.79 as of March 31, 2026.
Does BillionToOne Inc stock pay dividends?
No, BillionToOne Inc (BLLN) stock does not pay dividends to its shareholders as of March 31, 2026.
When is the next BillionToOne Inc dividend payment date?
BillionToOne Inc (BLLN) stock does not pay dividends to its shareholders.
What is the beta indicator for BillionToOne Inc?
BillionToOne Inc (BLLN) does not currently have a Beta indicator.